Cas9 Protein
Showing 1 - 25 of >10,000
Appetitive Behavior Trial in Leeds (Unheated Whey Protein (UWP) beverage, Heated Whey Protein (HWP) beverage, Casein (Cas)
Recruiting
- Appetitive Behavior
- Unheated Whey Protein (UWP) beverage
- +3 more
-
Leeds, West Yorkshire, United KingdomUniversity of Leeds
Apr 28, 2021
Viral Keratitis, Blindness Eye, Herpes Simplex Virus Infection Trial in Shanghai (BD111 Adult single group Dose)
Completed
- Viral Keratitis
- +3 more
- BD111 Adult single group Dose
-
Shanghai, Shanghai, ChinaEye & Ent Hospital of Fudan University
Aug 20, 2022
Gene Editing as a Therapeutic Approach for Rett Syndrome
Recruiting
- Rett Syndrome
- Gene editing in vitro
-
Siena, ItalyUniversity of Siena
Feb 13, 2023
Carbapenem-Resistant Enterobacteriaceae Infection Trial in Jinan (CAZ/AVI plus Aztreonam, Conventional treatment)
Recruiting
- Carbapenem-Resistant Enterobacteriaceae Infection
- CAZ/AVI plus Aztreonam
- Conventional treatment
-
Jinan, Shandong, ChinaMingju Hao
Apr 29, 2023
Glioblastoma Trial in Milwaukee (Gallium maltolate (500 mg), Gallium maltolate (1,000 mg), Gallium maltolate (1,500 mg))
Recruiting
- Glioblastoma
- Gallium maltolate (500 mg)
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Sep 20, 2022
COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant
Not yet recruiting
- COVID-19
- High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
- +3 more
- (no location specified)
Jun 19, 2023
Preeclampsia and Contact Activation
Completed
- Preeclampsia
- +2 more
- Pregnancy
-
Esbjerg, DenmarkThe Unit for Thrombosis Research, University of Southern Denmark
Nov 1, 2022
COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19
Not yet recruiting
- COVID-19
- Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
- Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
- (no location specified)
Jun 19, 2023
Exercise Training Trial in Toronto (Endurance exercise)
Completed
- Exercise Training
- Endurance exercise
-
Toronto, Ontario, CanadaGoldring Centre for High Performance Sport at the University of
Nov 15, 2023
Healthy Trial in Limerick (Seaweed protein)
Recruiting
- Healthy
- Seaweed protein
-
Limerick, IrelandUniversity of Limerick
May 9, 2023
Type 2 Diabetes Trial in Limerick (Seaweed protein, Maltodextrin)
Not yet recruiting
- Type 2 Diabetes
- Seaweed protein
- Maltodextrin
-
Limerick, IrelandUniversity of Limerick
Aug 14, 2023
Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)
Recruiting
- Clear Cell Renal Cell Carcinoma
- +4 more
- CTX131
-
Nashville, TennesseeResearch Site 1
Mar 21, 2023
COVID-19 Respiratory Infection Trial (PD-1 and ACE2 Knockout T Cells)
Not yet recruiting
- COVID-19 Respiratory Infection
- PD-1 and ACE2 Knockout T Cells
- (no location specified)
Aug 13, 2021
Contraceptives, Oral, Sex Hormone Trial in Toronto (Protein tracer drink)
Recruiting
- Contraceptives, Oral
- Sex Hormone
- Protein tracer drink
-
Toronto, Ontario, CanadaGoldring Centre for High Performance Sport at the University of
Nov 8, 2023
Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)
Not yet recruiting
- Beta-Thalassemia
- +6 more
- CTX001
- (no location specified)
Jul 26, 2022
G9a Protein and Clinical Outcome of Patients With Vulvar Cancer
Recruiting
- Vulvar Cancer, G9a Protein
- G9a protein
-
Banqiao, New Taipei, TaiwanFar Eastern Memorial Hospital
Aug 14, 2022
B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy Trial (CTX112)
Not yet recruiting
- B-cell Lymphoma
- +7 more
- CTX112
- (no location specified)
Dec 12, 2022
Transfusion Dependent Beta-Thalassaemia Trial in Guangzhou, Shenzhen, Tianjin (ET-01)
Active, not recruiting
- Transfusion Dependent Beta-Thalassaemia
- ET-01
-
Guangzhou, Guangdong, China
- +3 more
May 9, 2022
Interventional Trial in Toronto (Leucine enriched amino acids, Carbohydrate Placebo)
Recruiting
- Interventional
- Leucine enriched amino acids
- Carbohydrate Placebo
-
Toronto, Ontario, CanadaGoldring Centre for High Performance Sport at the University of
Jan 31, 2023
Metabolism, Exercise, Dietary Supplements Trial in Limerick (NEAA, PPI)
Completed
- Metabolism
- +2 more
- NEAA
- PPI
-
Limerick, Munster, IrelandUniversity of Limerick
Jun 20, 2022
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)
Active, not recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Stanford, California
- +11 more
Nov 30, 2022
NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- +5 more
- Fludarabine
- +4 more
-
Duarte, California
- +1 more
Dec 7, 2022
Protein Deficiency, Training Group, Sensitivity, Fatigue Trial in London (Ingestion of a Post-Workout Supplement, Ingestion of a
Completed
- Protein Deficiency
- +4 more
- Ingestion of a Post-Workout Supplement
- Ingestion of a Maltodextrin Supplement
-
London, Avery Hill, London., United KingdomUniversity of Greenwich, Avery Hill Campus, Sparrows Farm. Avery
Mar 2, 2023
S100A8/A9 and Innate Immunity in Liver Disease
Recruiting
- Cirrhosis, Liver
- +4 more
-
London Borough Of Wandsworth, London, United KingdomArjuna Singanayagam
Mar 30, 2023
Protein Deficiency, Training Group, Sensitivity, Fatigue Trial in London (Ingestion of a Pre-Workout Supplement, Ingestion of a
Not yet recruiting
- Protein Deficiency
- +4 more
- Ingestion of a Pre-Workout Supplement
- Ingestion of a Maltodextrin Supplement
-
London, Avery Hill, London., United KingdomUniversity of Greenwich, Avery Hill Campus, Sparrows Farm. Avery
Mar 2, 2023